Surfactant protein D as a biomarker for chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 9, Issue 6, 2012, Pages 651-653

  Bowler, Russell P ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

Adult; Biological markers; Bronchoalveolar lavage; Genetics; Phospholipids; Smoke

Indexed keywords

METHIONINE; SURFACTANT PROTEIN D; THREONINE; TOLL LIKE RECEPTOR 4;

AMINO ACID SUBSTITUTION; BACTERIAL CLEARANCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; GENETIC ASSOCIATION; HUMAN; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; LUNG LAVAGE; MICROBIAL ACTIVITY; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; GENETIC MARKERS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 84871498782     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.736317     Document Type: Review

References (31)

1. Mannino DM, et al. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ 2002; 51(6):1-16.
2. Sorensen GL, et al. Genetic and environmental infl uences of surfactant protein D serum levels. Am J Physiol Lung Cell Mol Physiol 2006; 290(5):L1010-1017.
3. Wright Jr. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005; 5(1):58-68.
4. McCormack FX, et al. Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 2003; 278(38):36250-36256.
5. Wu H, et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003; 111(10):1589-1602.
6. LeVine AM, et al. Surfactant protein D enhances clearance of infl uenza A virus from the lung in vivo. J Immunol 2001; 167(10):5868-5873.
7. LeVine AM, et al. Distinct Effects of surfactant protein A or D defi ciency during bacterial infection on the lung. J Immunol 2000; 165(7):3934-3940.
8. Ohya M, et al. Human pulmonary surfactant protein D binds the extracellular domains of Toll-like receptors 2 and 4 through the carbohydrate recognition domain by a mechanism diff erent from its binding to phosphatidylinositol and lipopolysaccharide. Biochemistry 2006; 45(28):8657-8664.
9. Yamazoe M, et al. Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced infl ammatory cell responses by altering LPS binding to its receptors. J Biol Chem 2008; 283(51):35878-35888.
10. Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Infl amm Res 2008; 57(11):497-503.
11. Numata M, et al. Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced infl ammation and infection. Proc Natl Acad Sci USA 2010; 107(1):320- 325.
12. Kuronuma K, et al. Anionic pulmonary surfactant phospholipids inhibit infl ammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2. J Biol Chem 2009; 284(38):25488- 25500.
13. Ishii T, et al. Involvement of surfactant protein D in emphysema revealed by genetic association study. Eur J Hum Genet 2012; 20(2):230-235.
14. Guo X, et al. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J 2001; 18(3):482-490.
15. Ishii T, et al. Association between genetic variations in surfactant protein d and emphysema, interstitial pneumonia, and lung cancer in a Japanese population. COPD 2012.
16. Foreman MG, et al. Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2011; 44(3):316-322.
17. Hersh CP, et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005; 33(1):71-78.
18. Finley TN, Ladman AJ. Low yield of pulmonary surfactant in cigarette smokers. N Engl J Med 1972; 286(5):223-227.
19. Honda Y, et al. Decreased contents of surfactant proteins A and D in BAL fl uids of healthy smokers. Chest 1996; 109(4):1006
20. Betsuyaku T, et al. Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fl uid. Eur Respir J 2004; 24(6):964-970.
21. More JM, et al. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease. BMC Pulm Med 2010; 10:53.
22. Schmekel B, et al. Recoveries of phosphatidylcholine and alveolar macrophages in lung lavage from healthy light smokers. Clin Physiol 1991; 11(5):431-438.
23. Mutti A, et al. Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest 2006; 129(5):1288-1297.
24. Lomas DA, et al. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J 2009; 34(1):95-102.
25. Kobayashi H, Kanoh S, Motoyoshi K. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking. Biomarkers 2008; 13(4):385-392.
26. Sin DD, et al. The Effects of fl uticasone with or without salmeterol on systemic biomarkers of infl ammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177(11): 1207-1214.
27. Winkler C, et al. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir Res 2011; 12:29.
28. Ju CR, Liu W, Chen RC. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease. Dis Markers 2012; 32(5):281-287.
29. Duvoix A, et al. Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPD. COPD 2011; 8(2):79-95.
30. Tkacova R, et al. Integrating lung and plasma expression of pneumo-proteins in developing biomarkers in COPD: a case study of surfactant protein D. Med Sci Monit 2010; 16(11):CR540-544.
31. Sin DD, Pahlavan PS, Man SF. Surfactant protein D: a lung specifi c biomarker in COPD? Ther Adv Respir Dis 2008; 2(2):65-74.